Thu.May 30, 2024

article thumbnail

Young-Onset Dementia Tied to Preeclampsia

Med Page Today

(MedPage Today) -- Preeclampsia raised the risk of young-onset dementia, a prospective study of nearly 2 million women in France showed. Compared with pregnancies without hypertensive disorders, preeclampsia more than doubled the risk of dementia.

Dementia 140
article thumbnail

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

DAIC

milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System. PPMC, part of the University of Pennsylvania Health System, renowned for advanced clinical research, innovation, and compassionate patient care, stands at the forefront as the

article thumbnail

Former Surgeon General's Exorbitant ED Bill: Impact of 'Cover Your Ass' Care

Med Page Today

(MedPage Today) -- In this exclusive video interview, Jeremy Faust, MD, editor-in-chief of MedPage Today, and Jerome Adams, MD, MPH, discuss Adams' recent emergency department (ED) bill and the many factors that can lead to a patient's "financial.

111
111
article thumbnail

AI-Powered Ultrasound Device Enhances Cardiac Monitoring for Chemotherapy Patients

DAIC

milla1cf Thu, 05/30/2024 - 10:22 May 30, 2024 — A recent study published in the European Heart Journal highlights the significant enhancements that the Kosmos ultrasound system, developed by EchoNous , brings to cardiac evaluations for chemotherapy patients. This AI-powered device enables even non-expert ultrasound users, such as junior oncologists and nurses, to accurately and swiftly assess left ventricular ejection fraction (LVEF), a crucial indicator of heart health and a critical measure

article thumbnail

New Psychedelic CPT Codes: Paving the Way for a New Age of Psychiatric Care

HCPLive

The new psychedelic CPT codes, effective January 1, 2024, could impact MDMA if approved. The FDA's Psychopharmacologic Drugs Advisory Committee will discuss MDMA on June 4.

98
article thumbnail

Cause of heart failure may differ for women and men

Science Daily - Heart Disease

A mouse study of heart failure with preserved ejection fraction (HFpEF) found male-female differences at the cellular level. The findings could have implications for how HFpEF is treated in women compared to men.

article thumbnail

Challenges and opportunities in patients with adult congenital heart disease, a narrative review

Frontiers in Cardiovascular Medicine

Adult congenital heart disease Pregnancy Transition of care Challenges heart failure.

More Trending

article thumbnail

Coronary Atherosclerotic Plaque Activity and Risk of MI

American College of Cardiology

Is vessel-level coronary atherosclerotic plaque activity using coronary 18F-sodium fluoride positron emission tomography (PET) associated with patient vessel-level myocardial infarction (MI)?

Plaque 68
article thumbnail

Five Benefits of Attending the STS Workshop on Robotic Cardiac Surgery

Society of Thoracic Surgeons - Congenital

The STS Workshop on Robotic Cardiac Surgery provided surgeons from across the country two days of hands-on team training for mitral valve repair, coronary bypass, and other surgery procedures in a cardiac robotics simulation environment.

article thumbnail

Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease

Cardiovascular Diabetology

Ischemia and no obstructive coronary artery disease (INOCA) is increasingly recognized and associated with poor outcomes. The triglyceride-glucose (TyG) index is a reliable alternative measure of insulin resis.

article thumbnail

Study Finds Stable Long-Term HRQoL in Patients with AATD-Associated Lung Disease

HCPLive

Patients with AATD-associated lung disease on augmentation therapy participating in a health management program experienced negligible changes in self-perceived health status.

59
article thumbnail

4 Northwell hospitals get top rating for cardiothoracic surgery

Becker's Hospital Review - Cardiology

Four New York-based Northwell Health hospitals received top ratings for cardiothoracic surgery specialties from the Society of Thoracic Surgeons.

article thumbnail

Remission Rates Comparable Between Biosimilar CT-P13, Originator in Bio-Naïve Crohn’s Disease

HCPLive

At week 54, the clinical remission rate among patients receiving originator infliximab was 92.5% compared with 100% in the biosimilar CT-P13 group.

59
article thumbnail

Cardiology pioneer, inventor dies suddenly

Becker's Hospital Review - Cardiology

Richard Heuser, MD, an internationally recognized cardiologist, inventor and educator, died May 23, according to an announcement on his website.

article thumbnail

Aligning With 2023 ESC Guidelines in oHCM Treatment

HCPLive

Anjali Tiku Owens, MD, explores the role of cardiac myosin inhibitors in the treatment strategies for patients with obstructive hypertrophic cardiomyopathy (oHCM), in accordance with the latest European Society of Cardiology (ESC) Guidelines released in 2023.

article thumbnail

Fostering Psychological Safety and Supporting Mental Health Among Cardiovascular Health Care Workers: A Science Advisory From the American Heart Association

Circulation

Circulation, Ahead of Print. The psychological safety of health care workers is an important but often overlooked aspect of the rising rates of burnout and workforce shortages. In addition, mental health conditions are prevalent among health care workers, but the associated stigma is a significant barrier to accessing adequate care. More efforts are therefore needed to foster health care work environments that are safe and supportive of self-care.

article thumbnail

Mavacamten in oHCM: Navigating the REMS Program for Safe, Optimal Outcomes

HCPLive

Anjali Tiku Owens, MD, examines mavacamten, the pioneering cardio myosin inhibitor (CMI) approved for the treatment of obstructive hypertrophic cardiomyopathy (oHCM), which is exclusively accessible through the restricted Risk Evaluation and Mitigation Strategy (REMS) program; the KOL delves into the objectives of this program and how it strives to enhance medication safety and optimize patient outcomes.

article thumbnail

The DC Ablation Method Was Found By Serendipity

HeartRhythm

As one of the first protagonists of the method of direct-current (DC) catheter ablation (also called “fulguration”) of cardiac arrhythmias, I was interested in the historical article on the “First Ablation” recently published by Dr Melvin Scheinman (1). Dr Scheinman and his collaborators played a tremendous role in the development and wide international acceptance of this method as he already detailed it in his first reflections on the topic in 2003 (2).

article thumbnail

Seltorexant Meets Primary, Secondary Endpoints in Phase 3 Trial for MDD, Insomnia

HCPLive

Announced on May 29, 2024, data from the MDD3001 trial indicate use of seltorexant was associated with meaningful improvements in depressive symptoms and sleep disturbances.

52
article thumbnail

Author’s Reply to The DC Ablation Method Was Found By Serendipity

HeartRhythm

The comments by Robert Frank regarding my recent description of the first planned ablation1 are much appreciated. Foremost, because it allows me to dispense with any feelings of ill will towards 2 people (Drs. Frank and Fontaine) who I greatly admire. I did not mention your case report in my original description since I was not aware of your report.

article thumbnail

Statins May Halt Cancer Development By Blocking Inflammatory Pathway

HCPLive

Blocking IL-33 production with statins may be an effective preventive strategy to suppress chronic inflammation and the development of certain cancers.

Cancer 52
article thumbnail

Temporary Permanent Pacemaker?

All About Cardiovascular System and Disorders

The term Temporary Permanent Pacemaker will seem to be a contradiction of terms, but it is a reality! One of the earliest reports of using temporary permanent pacemaker was in the setting of an infected cardiac implantable electronic device (CIED) in a pacemaker dependent patient. In such a patient, a temporary pacemaker wire may be required for long periods during antibiotic treatment.

article thumbnail

Greater Levels of Physical Activity Linked to Reduced Risk of Hyperuricemia

HCPLive

The analysis of NHANES data revealed a dose-response association between weekly moderate-to-vigorous physical activity levels and hyperuricemia risk.

52
article thumbnail

Dual Pathway Inhibition in Stable Cardiovascular Disease: It Takes Two to Tango!

Journal of Cardiovascular Pharmacology

An abstract is unavailable. This article is available as a PDF only.

article thumbnail

Robert Rosenson, MD: ARCHES-2 and Zodasiran in Mixed Hyperlipidemia

HCPLive

Robert Rosenson, MD, discusses the results of the ARCHES-2 trial and how it informs the potential of ANGPTL3 inhibition as well as RNAi therapies.

52
article thumbnail

Elixir Medical PINNACLE I Study of LithiX IVL System Meets Primary Endpoints of Clinical Success

DAIC

Elixir Medical recently announced that the PINNACLE I study, evaluating the safety and performance of its LithiX Hertz Contact Intravascular Lithotripsy System (IVL) met its primary safety and effectiveness endpoint of clinical success. Shown here: Elixir Medical CEO Motasim Sirhan. Image courtesy: Elixir Medical christine.book Thu, 05/30/2024 - 10:36 May 30, 2024 — Elixir Medical , a developer of technologies to treat cardiovascular and peripheral disease, announced during the recent Euro PCR 2

Stent 105
article thumbnail

Degenerative MR Due to Flail Leaflet According to Sex

American College of Cardiology

What are the sex-specific baseline clinical and echocardiographic characteristics at referral for degenerative mitral regurgitation (DMR) due to flail leaflets and subsequent management and outcomes?

article thumbnail

One-Year BIONETIC-I Study Results Show Safety and Effectiveness of Iliac Artery Treatment With BIOTRONIK’s Dynetic-35 Cobalt Chromium Balloon-Expandable Stent System

DAIC

milla1cf Thu, 05/30/2024 - 10:14 May 30, 2024 — B iotronik announced the presentation of the 12-month results from the BIONETIC-I study this week at LINC 2024. The prospective, international, multicenter single-arm observational study evaluated the treatment of de novo, restenotic or occluded iliac lesions in 160 patients with Rutherford Class 2-6 peripheral artery disease using the Dynetic-35 cobalt chromium balloon-expandable stent system.

Stents 69